KDM6A Lysine Demethylase Directs Epigenetic Polarity of MDSCs during Murine Sepsis

• Published in: Journal of Innate Immunity
• Main Authors: Isatou Bah, Tuqa Alkhateeb, Dima Youssef, Zhi Q. Yao, Charles E. McCall, Mohamed El Gazzar
• Format: Article
• Language: English
• Published: Karger Publishers 2021-07-01
• Subjects: sepsis; myeloid-derived suppressor cell; immune suppression; hotairm1; epigenetics
• Online Access: https://www.karger.com/Article/FullText/517407

Sepsis-induced myeloid-derived suppressor cells (MDSCs) increase mortality risk. We previously identified that long non-coding RNA Hotairm1 supports myeloid precursor shifts to Gr1+CD11b+ MDSCs during mouse sepsis. A major unanswered question is what molecular processes control Hotairm1 expression. In this study, we found by a genetic deletion that a specific PU.1-binding site is indispensable in controlling Hotairm1 transcription. We then identified H3K4me3 and H3K27me3 at the PU.1 site on the Hotairm1 promoter. Controlling an epigenetic switch of Hotairm1 transcription by PU.1 was histone KDM6A demethylase for H3K27me3 that derepressed its transcription with possible contributions from Ezh2 methyltransferase for H3K27me3. KDM6A knockdown in MDSCs increased H3K27me3, decreased H3K4me3, and inhibited Hotairm1 transcription activation by PU.1. These results enlighten clinical translation research of PU.1 epigenetic regulation as a potential sepsis immune-checkpoint treatment site.